November 28th 2025, 2:00pm
Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.
November 26th 2025, 9:00pm
CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.
November 26th 2025, 2:00pm
After more than 30 years since she was first diagnosed with a myeloproliferative neoplasm, Nona Baker is hopeful for the future thanks to current clinical trial landscape.
November 24th 2025, 2:00pm
Dr. Pamela L. Kunz sat down for an interview with CURE to discuss resources and ongoing initiatives that may help patients with this disease.
November 24th 2025, 1:12pm
Panelists discuss how healthcare providers and patients should understand that talquetamab's unique side effects are temporary and resolve over time even while continuing treatment, emphasizing the drug's excellent efficacy and the importance of removing stigma around its manageable toxicity profile.
November 24th 2025, 1:11pm
Panelists discuss how effective caregivers should join support groups, maintain detailed records of symptoms and medications, attend all appointments, stay informed about myeloma research, and serve as active advocates who can communicate with healthcare teams when patients cannot.
November 24th 2025, 1:10pm
Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational materials, and understand that while initial side effects can be challenging, they are temporary and manageable with proper preparation and support.
November 24th 2025, 1:09pm
Panelists discuss how patients can maintain nutrition during talquetamab treatment by focusing on texture and food presentation when taste is impaired, using high-calorie options, and remembering that taste changes and dry mouth are temporary side effects that improve over time.
November 24th 2025, 1:08pm
Panelists discuss how specific talquetamab-related side effects like skin peeling, nail changes, and rashes can be effectively managed through targeted interventions including topical treatments, protective measures, and preventive strategies tailored to the drug's unique toxicity profile.
November 24th 2025, 1:07pm
Panelists discuss how healthcare providers can develop comprehensive management protocols for talquetamab-related toxicities by consulting with specialists, gathering patient feedback, and creating detailed handouts that empower patients to proactively manage side effects before they begin treatment.
Delving into Recent Advancements in Lung Cancer Care
Understanding Minimally Invasive Lung Cancer Care Advancements
Making Breast Cancer Surgery Easier and Faster to Recover From
Expert Shares Advice for Navigating a New Lung Cancer Diagnosis